Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dong-Bo Wu

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|February 6, 2013
Preliminary study on the application of an umbrella-like abdominal wall-lifting device in gasless laparoscopic surgeryDong-Bo Wu, Sheng-Fu Yang, Kui-Hua Geng, et al.
Virology Journal|April 4, 2018
The truncated mutant HBsAg expression increases the tumorigenesis of hepatitis B virus by regulating TGF-β/Smad signaling pathwayMeng-Lan Wang, Dong-Bo Wu, Ya-Chao Tao, et al.
Journal of Viral Hepatitis|November 1, 2018
Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real-world experience of a retrospective studyDong-Bo Wu, Wei Jiang, Yong-Hong Wang, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|July 1, 2009
[Study on visualized virtual surgery of living-related donor liver transplantation]Chi-Hua Fang, Dong-Bo Wu, Yan-Peng Huang, et al.
Journal of Viral Hepatitis|February 13, 2020
Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatmentYa-Chao Tao, Meng-Lan Wang, Dong-Mei Zhang, et al.
Journal of Medical Virology|October 15, 2019
Tenofovir monotherapy versus tenofovir plus entecavir combination therapy in HBeAg-positive chronic hepatitis patients with partial virological response to entecavirYong-Hong Wang, Juan Liao, Dong-Mei Zhang, et al.
Medicine|October 30, 2020
Efficacy and safety of sofosbuvir-based pangenotypic direct-acting antiviral agents for chronic hepatitis C patients without genotype determination: Real-world experience of a retrospective studyJuan Li, Dong-Bo Wu, Wei Jiang, et al.
Frontiers in Medicine|August 23, 2021
Retrospective Analysis of the Clinical Efficacy of N-Acetylcysteine in the Treatment of Hepatitis B Virus Related Acute-on-Chronic Liver FailureMeng-Lan Wang, Xiu-Jun Yin, Xue-Lian Li, et al.
Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|August 1, 2020
TRAIL inhibits HBV replication and expression by down-regulating liver-enriched transcription factorsJuan Li, Fan-Wei Liu, Dong-Bo Wu, et al.
Clinics and Research in Hepatology and Gastroenterology|November 6, 2012
Expression of TRAIL in liver tissue from patients with different outcomes of HBV infectionFan-wei Liu, Dong-bo Wu, En-qiang Chen, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Journal of Laparoendoscopic & Advanced Surgical Techniques. Part A|February 6, 2013
Preliminary study on the application of an umbrella-like abdominal wall-lifting device in gasless laparoscopic surgeryDong-Bo Wu, Sheng-Fu Yang, Kui-Hua Geng, et al.
Virology Journal|April 4, 2018
The truncated mutant HBsAg expression increases the tumorigenesis of hepatitis B virus by regulating TGF-β/Smad signaling pathwayMeng-Lan Wang, Dong-Bo Wu, Ya-Chao Tao, et al.
Journal of Viral Hepatitis|November 1, 2018
Safety and efficacy of sofosbuvir-based direct-acting antiviral regimens for hepatitis C virus genotype 6 in Southwest China: Real-world experience of a retrospective studyDong-Bo Wu, Wei Jiang, Yong-Hong Wang, et al.
Zhonghua Wai Ke Za Zhi [Chinese Journal of Surgery]|July 1, 2009
[Study on visualized virtual surgery of living-related donor liver transplantation]Chi-Hua Fang, Dong-Bo Wu, Yan-Peng Huang, et al.
Journal of Viral Hepatitis|February 13, 2020
Optimal drug administration manner would rescue partial virological response in chronic hepatitis B patients with entecavir or tenofovir treatmentYa-Chao Tao, Meng-Lan Wang, Dong-Mei Zhang, et al.
Journal of Medical Virology|October 15, 2019
Tenofovir monotherapy versus tenofovir plus entecavir combination therapy in HBeAg-positive chronic hepatitis patients with partial virological response to entecavirYong-Hong Wang, Juan Liao, Dong-Mei Zhang, et al.
Medicine|October 30, 2020
Efficacy and safety of sofosbuvir-based pangenotypic direct-acting antiviral agents for chronic hepatitis C patients without genotype determination: Real-world experience of a retrospective studyJuan Li, Dong-Bo Wu, Wei Jiang, et al.
Frontiers in Medicine|August 23, 2021
Retrospective Analysis of the Clinical Efficacy of N-Acetylcysteine in the Treatment of Hepatitis B Virus Related Acute-on-Chronic Liver FailureMeng-Lan Wang, Xiu-Jun Yin, Xue-Lian Li, et al.
Arab Journal of Gastroenterology : the Official Publication of the Pan-Arab Association of Gastroenterology|August 1, 2020
TRAIL inhibits HBV replication and expression by down-regulating liver-enriched transcription factorsJuan Li, Fan-Wei Liu, Dong-Bo Wu, et al.
Clinics and Research in Hepatology and Gastroenterology|November 6, 2012
Expression of TRAIL in liver tissue from patients with different outcomes of HBV infectionFan-wei Liu, Dong-bo Wu, En-qiang Chen, et al.
Pageof 4